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This article presents a dataset proving the simultaneous presence
of a 50UTR-truncated PDHA1 mRNA and a full-length PDHA2 mRNA
in the somatic cells of a PDC-deﬁcient female patient and all
members of her immediate family (parents and brother).
We have designed a large set of primer pairs in order to per-
form detailed RT-PCR assays allowing the clear identiﬁcation of
both PDHA1 and PDHA2 mRNA species in somatic cells. In addition,
two different experimental approaches were used to elucidate the
copy number of PDHA1 gene in the patient and her mother.
The interpretation and discussion of these data, along with
further extensive experiments concerning the origin of this
altered gene expression and its potential therapeutic con-
sequences, can be found in “Complex genetic ﬁndings in a female
patient with pyruvate dehydrogenase complex deﬁciency: null
mutations in the PDHX gene associated with unusual expressionvier Inc. This is an open access article under the CC BY license
/j.gene.2016.06.041
emistry and Human Biology, Faculty of Pharmacy, Universidade deLisboa,
.
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A. Pinheiro et al. / Data in Brief 9 (2016) 68–77 69of the testis-speciﬁc PDHA2 gene in her somatic cells” (A. Pin-
heiro, M.J. Silva, C. Florindo, et al., 2016) [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc sub-
ject areaMolecular Geneticsype of data Tables, ﬁgures
ow data was
acquiredAgarose gel electrophoresis after RT-PCR analyses quantitative real time PCR,
microarray analyses, in silico analyses (BLAST software)ata format Raw, analyzed
xperimental
factorsGenomic DNA and total RNA isolated from whole blood samples and ﬁbroblast
culturesxperimental
featuresGenomic DNA was ampliﬁed by quantitative real time PCR and microarray
analyses. Total RNA was reverse transcribed and ampliﬁed by semi-quantitative
RT-PCR and by quantitative real time PCR using TaqMan assays. Alignment of
sequences was performed using the BLAST software.ata source
locationLisboa, Portugalata accessibility Data provided within the manuscript and available in public databases (NCBI) in
case of sequence alignment: GenBank accession numbers GenBank: NM_
000284.3 (PDHA1) and GenBank: NM_005390.4 (PDHA2)Value of the data
 These data, reporting on PDHA2 gene expression in somatic cells, may trigger new research related
to the activation of a paralogue gene as a therapeutic target to loss-of-function mutations.
 Data revealing the co-existence of both PDHA1 and PDHA2mRNAs in somatic cells will be useful for
future experiments addressing the impact between both isoforms in the assembly of a fully
functional PDC.
 Data concerning gene copy number may assist the choice of the underlying methodology.
 These dataset may contribute for designing further experiments aiming the development of
alternative therapies for metabolic disorders.1. Data
The E1 rate-limiting enzyme of pyruvate dehydrogenase complex (PDC) is a heterotetramer (α2β2)
and its α subunit is encoded by PDHA1 gene, located in X chromosome and presenting ubiquitous
expression in somatic tissues. Nevertheless a paralogue gene exists, PDHA2, which is located in
chromosome 4 and expressed only in spermatocytes and spermatids [2].
Table 1 shows the primers used for the ampliﬁcation of the analyzed genes, according to the used
methodology. Fig. 1 presents the results of PDHA1 and PDHA2 gene expression in somatic cells of the
individuals under study and in controls. Fig. 2 displays the alignment of PDHA1 and PDHA2 mRNAs
Table 1
List of primers used in this study.
Primer Sequence Position
cDNA ampliﬁcation
PDHA1 messenger
PDHA1-F 50–AGCATCCCGTAATTTTGC–30 þ75 to þ92
PDHA1-R 50–CTTTAGTTCTTCCACACTGG–30 þ989 to þ1008
PDHA1-5’-F 50–GGGCACCTGAAGGAGACTT–30 85 to 66
PDS1 50–TGTGAGGAGTCGCCGCTGCC–30 37 to 18
PDSTr-F 50–GCCACTGCCTGTGCTTCAT–30 17 to þ2
PDSTr-R 50–ACTCCATTCGGCGTACAGTCT–30 þ207 to þ226
PDHA2 messenger
PDHA2-F 50–TGCCATCTACAGCACTCCGT–30 27 to 8
PDHA2-R 50–CCTCCTTGAGTTGAGAACAC–30 þ1235 to þ1254
PDHX messenger
PXF2 50–CTGCTGCGTTATCTTGTGGGCT–30 þ37 to þ58
PXW2 50–TGAGTGAATGTGCCCACTGCATTG–30 þ812 to þ835
PXP2 50–CAATGCAGTGGGCACATTCACTGA–30 þ812 to þ835
PXR2 50–TAACAACTACTGAATCAACTAAGC–30 þ2060 to þ2083
Genomic DNA ampliﬁcation
PDHA1 gene
PDHA1-P1-F 50–CCCTTGTTGCTTTGGTGTTT–30 4383 to 4403
PDHA1-P1-R 50–AGATTGCTCTGCTGACTACCG–30 4762 to 4784
PDHA1-P2-F 50–TGAGCATGCTGCTAATCTTCA–30 4642 to 4682
PDHA1-P2-R 50–CGGCGTGACAGAGTCGTAAT–30 5114 to 5133
PDHA1-P3-F 50–CTGGACGCCGTTCTGGTT–30 4966 to 2983
PDHA1-P3-R 50–GCGGAGGCGAAGTAAAGG–30 4323 to 4340
PDHA1-P4-F 50–TGCTTCATGAGGAAGATGCT–30 5140 to 5159
PDHA1-P4-R 50–AGGGTGCTGTTTGAACGAAG–30 5526 to 5645
PDHA2 gene
PDHA2-A-F 50–GAGTAAGGAAAAGTGGAATGTCA–30 841 to 819
PDHA2-A-R 50–ATCCTGCTCCATAATGTGCC–30 200 to 181
PDHA2-B-F 50–GCCATCAGGATAAATGTGGC–30 657 to 638
PDHA2-B-R 50–CCCTTTTCCCTGTTAAACCC–30 322 to 303
PDHA2-C-F 50–AACTCTCAGAACTCTCATGTGCC–30 415 to 393
PDHA2-C-R 50–ACGGAGTGCTGTAGATGGCA–30 27 to 8
PDHA2-D-F 50–CAGGACCTGCCTCTATCACC–30 142 to þ123
PDHA2-D-R 50–AAACCGCGAATGAATTTCTG–30 þ244 to þ263
PDHA2-F-F 50–GCATGGAATTGAAGGCAGAT–30 þ212 to þ231
PDHA2-F-R 50–CCTCCTTGAGTTGAGAACAC–30 þ1298 toþ1317
PDHX gene
PX1F 50–AGAGACCTAAAGGCACCGCT–30 þ5414 to þ5433
PX1R 50–AAGCAGGCCCTCAATCATAA–30 þ5751 to þ5770
PX2F 50–TGGGAATCTTTTAGACTTTGGA–30 þ20,144 to þ 20,165
PX2R 50–TGCTGAACCCAGAAAACCTT–30 þ20,531 to þ 20,550
PX3F 50–CAACCCAGAAATAGCTACGGA–30 þ36,259 to þ 36,279
PX3R 50–CACATTAAAAATAAGGAGGCAAAA–30 þ36,557 to þ 36,581
PX4F 50–TGCAGTCATGGGGTTTTACTT–30 þ46,205 to þ 46,225
PX4R 50–ACAGCAACTTCCTACGTGATG–30 þ46,549 to þ46,570
PX5F 50–GTGACCATCTGTGGGAGTCA–30 þ49,159 to þ49,173
PX5R 50–TTATTCAGAAAACAACTCTTGCAT–30 þ49,549 to þ49,573
PX6F 50–TCACCTGCGTTTTCTGAAAGT–30 þ55,435 to þ 55,456
PX6R 50–GTGAGCCAAGATTGTGCCAT–30 þ55,779 to þ55,798
PX7F 50–TTCCACTTGTGGTTTAACGGA–30 þ58,968 to þ58,988
PX7R 50–TTTCCTCTAGCACAAATATACCCA–30 þ59,294 to þ59,318
PX8F 50–ACAAGTTTGAAGTTGTAATGGTCA–30 þ66,918 to þ66,941
PX8R 50–GAGGGAGATCAAACGATAGGA–30 þ67,178 to þ67,198
PX9F 50–TTTTTCTGTAACCGCCTTGG–30 þ73,376 to þ73,395
PX9R 50–TCTCCCCTTCACACACACAA–30 þ73,700 to þ73,719
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Table 1 (continued )
Primer Sequence Position
PX10F 50–GGTAACAAAATCAAATCAAGGCA–30 þ81,064 to þ81,085
PX10R 50–TTCAGATAAATGAAAGGCTGACA–30 þ81,315 to þ81,337
PX11F 50–ACGGAAAGGGGACTTTGATT–30 þ83,725 to þ83,744
PX11R 50–TTGAGGACTAGGCAAGTCGG–30 þ84,031 to þ84,050
PDHA2 gene methylation analysis
CpGI-M-F 50–ATAAATTAGTTAGTTTAGGTTGCGT–30 188 to 164
CpGI-M-R 50–ATAACGTCATTTAAAAAATTACGAA–30 þ74 to þ98
CpGI-U-F 50–ATAAATTAGTTAGTTTAGGTTGTGT–30 188 to 64
CpGI-U-R 50–ATAACATCATTTAAAAAATTACAAA–30 þ74 to þ98
CpGII-F 50–TGGAATTGAAGGTAGATTAGTTGTATAAAT–30 þ205 toþ234
CpGII-R 50–ATACCATTACCCCCATAAAAATTCT–30 þ406 to þ431
Gene dosage analysis
PDHA1 gene
PDHA1-exon7F 50–AGGAGGCCTTTCTGTGCTTT–30 11,341 to 11,359
PDHA1-exon7R 50–CGGCCCCACCACAGGGTTCCT–30 11,616 to 11,636
PAH gene
PAH-exon1F 50–GCTTTACTGTGCGGAGATCACCAC–30 5315 to 5339
PAH-exon1R 50–CTTATGAAACCAGGAAGCAC–30 5606 to 5625
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between the two genes, thus proving the simultaneous presence of both transcripts. Fig. 3 depicts the
scheme of PDHA1 mRNA with the localization of all the primers used to prove the presence of the
50UTR truncated PDHA1 mRNA detected in the family samples, and to localize the truncation point.
Table 2 and Fig. 4 show the results of the two different methodologies used to evaluate PDHA1 gene
copy number: quantitative real time PCR (Table 2) and microarray analyses (Fig. 4).2. Experimental design, materials and methods
2.1. Sample preparation
Lymphocytes were isolated from three independent peripheral blood samples obtained from the
index case and her parents and brother, as well as from control individuals.
Patient's ﬁbroblast cultures were established from a diagnostic skin biopsy and grown under
standard conditions.
Positive controls for PDHA2 gene expression were obtained from two different sources; a com-
mercially available human testis total RNA sample (Clontech Laboratories Inc., Mountain View, CA,
USA) and human testis specimens from eight cases requiring open testicular biopsy for the retrieval of
testicular sperm for intracytoplasmic sperm injection [3].
2.2. Nucleic acids preparation
Genomic DNA, total RNA and cDNA were prepared according to standard methods and described
in [1].
Fig. 1. RT-PCR analyses of PDH E1α transcripts. (a) Using PDHA1 and PDH2 speciﬁc primers. PL - patient lymphocytes; PF -
patient ﬁbroblasts; T - whole testis tissue; C1 and C2 - control lymphocytes; B1 without PCR control using whole testis total
RNA; B2 - PCR control using no biological sample. M - 100 Base Pair Ladder (New England Biolabs). (b) Using forward PDS1
primer and reverse PDHA1 speciﬁc primer. PL - patient lymphocytes; PF - patient ﬁbroblasts; C - control lymphocytes; B2 - PCR
control using no biological sample. M - 100 Base Pair Ladder (New England Biolabs).
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Ampliﬁcation of the 11 individual exons of the PDHA1 gene and related intron–exon boundaries
were ampliﬁed using primers already published [4]. PDHA1 and PDHA2 cDNAs were ampliﬁed under
conditions previously described [5] and using primers listed in Table 1, which were designed to
annealing to regions displaying no homology between transcripts [6].2.4. Evaluation of PDHA1 and PDHA2 expression and PDHA1 gene dosage
PDHA1 and PDHA2 transcriptional levels were evaluated by quantitative real time RT-PCR under
conditions previously described [1].
The copy number of PDHA1 gene was evaluated by two methods, quantitative real time PCR and
microarray analysis, as previously described [1].
Fig. 2. Alignment of PDHA1 and PDHA2 cDNA sequences and primers’ localization.
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Fig. 2. (continued)
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Fig. 2. (continued)
A. Pinheiro et al. / Data in Brief 9 (2016) 68–77 75
Fig. 2. (continued)
Fig. 3. Schematic representation of the PDHA1 mRNA sequence showing the ampliﬁed versus non-ampliﬁed products in the
RT-PCR analysis with the corresponding localization of the forward primers (PDHA1-50 , PDS1, PDSTrF, PDHA1F) and reverse
primers (PDHA1R and PDSTrR), as well as the identiﬁcation of the predicted truncation point.
Table 2
Calculations for determining by qPCR the copy number of PDHA1 gene using as reference the autosomal PAH gene.
PDHA1 gene
Sample Ave ΔCt ΔΔCt RQ (2-ΔΔCt) Copy # (2RQ)
Patient 0.26 0.91 0.5 1
Control Female 1 0.65 0 1 2
Control Female 2 0.33 0.32 0.8 2
Control Female 3 0.59 0.06 0.9 2
Control Male 1 0.93 1.58 0.3 1
Control Male 2 0.23 0.42 0.7 1
Control Male 3 0.01 0.64 0.6 1
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Fig. 4. Detailed view of the PDHA1 region on chromosome X. (a) Allele difference and (b) copy number state showing absence
of big deletions involving the gene. (c) OMIM genes: PDHA1 (dark green horizontal bar) and MAP3K15 (gray horizontal bar).
Intron - horizontal pink lines; Exon - vertical pink bars. (d) Markers present in PDHA1 region. Dark green - non-polymorphic
probes; Light green - SNP, single nucleotide polymorphism. (For interpretation of the references to color in this ﬁgure legend,
the reader is referred to the web version of this article).
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